High-dose intravenous corticosteroid therapy for Graves' ophthalmopathy

Journal of Endocrinological Investigation
P E MacchiaG Fenzi

Abstract

In order to compare oral and high-dose iv corticosteroid therapy for Graves' disease, 25 patients with Graves' ophthalmopathy were treated with two weekly iv injections of 1 g of methylprednisolone diluted in 250-500 ml of physiological solution for 6 weeks, and were compared to a group of 26 patients treated with oral prednisone at a dose of 60-80 mg/day progressively reduced every 2 weeks for a total duration of 4-6 months. The efficacy of treatment was evaluated using the ophthalmopathy index score. Patients were followed at 3, 6, 12 months, and afterwards yearly. All patients showed a significant improvement in signs and symptoms of orbital inflammation and a slight improvement in proptosis and diplopia. Relevant side-effects were reported from patients receiving oral therapy, but no significant side-effects were observed in patients treated with high iv doses; a few cases presented with gastric pain (highly sensitive to aluminium oxide or ranitidine), while most of the patients referred to cutaneous rashes and a metal taste that disappeared some hours after the infusion. Improvements observed after treatment have been stable in both groups. In conclusion, in addition to a lower incidence of side-effects compared to the cla...Continue Reading

References

Sep 19, 1992·BMJ : British Medical Journal·A M Thompson
Jan 1, 1992·Thyroid : Official Journal of the American Thyroid Association
Jan 1, 1992·Acta Endocrinologica·A AntonelliL Baschieri
May 1, 1991·Experimental and Clinical Endocrinology·L BartalenaA Pinchera
Dec 17, 1988·BMJ : British Medical Journal·P Kendall-TaylorK Hall
Oct 1, 1987·The Journal of Clinical Endocrinology and Metabolism·R S BahnC M Johnson
Jun 27, 1974·The New England Journal of Medicine·S C WernerL A Franzen
Jun 1, 1994·Journal of Endocrinological Investigation·M MengistuK D Burman
Jan 1, 1994·Thyroid : Official Journal of the American Thyroid Association·H KoshiyamaT Misaki
Feb 1, 1993·Endocrine Journal·Y HiromatsuN Kaise
Nov 1, 1994·The Journal of Clinical Endocrinology and Metabolism·R PaschkeM Ludgate
Dec 1, 1993·Endocrine Reviews·H B Burch, L Wartofsky
Apr 27, 2000·Endocrine Reviews·L BartalenaC Marcocci

❮ Previous
Next ❯

Citations

Mar 27, 2012·Indian Journal of Ophthalmology·Rajat Maheshwari, Ezekiel Weis
Feb 11, 2012·Journal of Endocrinological Investigation·S ZangG J Kahaly
Feb 23, 2012·Current Neurology and Neuroscience Reports·Erin F GillespieRaymond S Douglas
Nov 8, 2011·European Journal of Endocrinology·Claudio MarcocciUNKNOWN European Group of Graves' Orbitopathy
Feb 16, 2016·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Ji Won KimJin Sook Yoon
May 29, 2012·Best Practice & Research. Clinical Endocrinology & Metabolism·Claudio Marcocci, Michele Marinò
Mar 27, 2012·The Medical Clinics of North America·Marius N StanRebecca S Bahn
Mar 13, 2014·Clinical & Experimental Ophthalmology·Guohong GaoFei Ma
Dec 19, 2015·International Journal of Endocrinology·Kai-Ling YongLay Leng Seah
Jul 12, 2014·Practical Radiation Oncology·Ezra HahnCaroline Chung
Jan 1, 2011·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Dawn D YangVikram D Durairaj
Apr 2, 2016·European Journal of Endocrinology·Irene CampiMario Salvi
Sep 27, 2007·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Christopher I ZoumalanSteven E Feldon
Mar 18, 2008·Thyroid : Official Journal of the American Thyroid Association·Luigi BartalenaWilmar M Wiersinga
Oct 28, 2011·Thyroid : Official Journal of the American Thyroid Association·Hanna Wichary, Teresa Gasińska
Nov 10, 2009·Thyroid : Official Journal of the American Thyroid Association·Maria E LendorfUlla Feldt-Rasmussen
Sep 19, 2006·Drugs·Sara P ModjtahediIgal Leibovitch
Jun 22, 2010·Ophthalmic Plastic and Reconstructive Surgery·Rona Z SilkissSimeon A Lauer
Jun 6, 2009·The Journal of Clinical Endocrinology and Metabolism·Hadas Stiebel-KalishLeonard Leibovici
Mar 31, 2010·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Sara MadaschiRoberto Lanzi
Mar 13, 2012·Expert Opinion on Pharmacotherapy·Claudio MarcocciMarenza Leo
May 14, 2014·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·M Tariq Bhatti, Jonathan J Dutton
Jan 11, 2020·International Ophthalmology·Jessica M Pouso-DizFrancisco Gonzalez
Jul 6, 2019·The British Journal of Ophthalmology·Xiaoxin ZhouGuangmin Chen
Nov 14, 2018·International Journal of Endocrinology·Piotr MiśkiewiczUrszula Ambroziak
Jan 1, 2020·Thyroid Research·Dorota Walasik-SzemplińskaIwona Sudoł-Szopińska
Jun 17, 2020·Journal of Korean Medical Science·Hwa Young Ahn, Jeong Kyu Lee
Jan 1, 2019·BioMed Research International·Xiaofang TuQing Su
May 25, 2020·The British Journal of Ophthalmology·Jwu Jin Khong, Alan McNab
Oct 19, 2020·Medicina clínica·Andrés González-García, Marco Sales-Sanz
Jan 7, 2021·Therapeutic Advances in Endocrinology and Metabolism·Jan LängerichtGeorge J Kahaly

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.